JOSE PABLO
MIRAMONTES GONZALEZ
PROFESOR CONTRATADO DOCTOR
Hospital Universitario de Valladolid
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (20)
2024
-
COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study
Journal of Infection and Public Health, Vol. 17, Núm. 6, pp. 939-946
-
How to detect non-institutionalized older patients at risk of malnutrition during their hospitalization? Comparison of 8 screening tools for malnutrition or nutritional risk
Revista Clinica Espanola, Vol. 224, Núm. 4, pp. 217-224
2023
-
Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial
European Journal of Clinical Investigation, Vol. 53, Núm. 1
-
High cobalamin levels as a five-year risk predictor for developing hematological cancer
Minerva medica, Vol. 114, Núm. 1, pp. 22-28
2022
-
Association of blood group A with hospital comorbidity in patients infected by SARS-CoV-2
Medicina Clinica, Vol. 159, Núm. 1, pp. 27-30
-
Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic
Journal of Clinical Medicine, Vol. 11, Núm. 12
2021
-
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study
Atherosclerosis, Vol. 317, pp. 52-58
-
Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection
Journal of Personalized Medicine, Vol. 11, Núm. 7
-
Is Nutrition the Forgotten Risk Factor in COVID-19 Infection?
Revista Clinica Espanola
-
Porcelain aorta
Revista Clinica Espanola, Vol. 221, Núm. 8, pp. 493
-
Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles
Journal of Clinical Medicine, Vol. 10, Núm. 22
-
Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
Sclerodermiform Syndrome Induced by Hydroxycarbamide
Journal of Clinical Rheumatology
-
The nutritional status of the elderly patient infected with COVID-19: the forgotten risk factor?
Current Medical Research and Opinion, Vol. 37, Núm. 4, pp. 549-554
2020
-
Black esophagus and diabetes: a close relationship
Cardiovascular Endocrinology and Metabolism, Vol. 10, Núm. 1, pp. 59-61
-
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834
-
Is the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease?
Kidney International
2019
-
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
Journal of Clinical Lipidology, Vol. 13, Núm. 6, pp. 989-996
-
Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months
Diabetes Research and Clinical Practice, Vol. 158
2006
-
Degree of public awareness regarding intensive care units (ICUs) and intensive care physicians in Castilla y León
Medicina Intensiva, Vol. 30, Núm. 2, pp. 45-51